Tilikum Therapeutics

Private

Boston, MassachusettsHealthcare & Life Scienceshttps://tilikumtx.com/

Last Round

Seed

Jun 1, 2023

Company Overview

Tilikum Therapeutics is a biotechnology company developing a new class of small-molecule PARP1-selective inhibitors to treat treatment-resistant solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

PARP inhibitoroncologybiotechnologydrug discoverysolid tumorsPARP-lockingsmall-molecule inhibitorprecision medicinecancer therapeuticsclinical-stage biotechbiopharmadrug pipelineDNA-repairtherapeutic assets

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tilikum Therapeutics Comparables

Compare Tilikum Therapeutics with similar companies based on industry and business-model similarity.

Tilikum Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Acerand Therapeutics	87%
Eikon Therapeutics	76%
IMPACT Therapeutics	73%

View all Comparables

Tilikum Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 1, 2023

View all Funding Rounds

Tilikum Therapeutics Investors

Notable investors and investment history

Tilikum Therapeutics investors
Investor	Rounds
Delin Ventures	Seed

View all Investors

Tilikum Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Tilikum Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tilikum Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts

Year Founded2022

Last FundingJun 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.